Neoantigen × AI
Daily research signal
45Brief

Two advances streamline neoantigen vaccine development

Two methodological advances aim to streamline neoantigen vaccine development: one leverages programmable RNA editing to engineer immunogenic 'editopes' directly within tumor cells, while another proposes allogeneic dendritic cell lines to overcome the reproducibility issues inherent in autologous DC-based platforms.PubMedmedicalxpress.com

1new story1 in context
AI / Methods2 days agoNew

Engineering editopes through programmable RNA editing toward tumor neoantigen generation.

Researchers developed SPEAR gRNAs to harness endogenous ADAR1 for precise A-to-I RNA editing, creating immunogenic neoepitopes termed 'editopes.' In a melanoma model using the MART-1 antigen, this approach restored T-cell recognition and enabled tumor control in vivo. The team also established a computational pipeline to identify candidate tumor-selective neoepitopes across multiple cancer types.

europepmc · 2 days ago · Pecori R, Casati B, Merdler-Rabinowicz R, Landesman N, Sanghvi K, Zens S, Bilgin E, Topouz

01

Relevant work from earlier we're still surfacing — not today's news.